<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">JBiSE</journal-id><journal-title-group><journal-title>Journal of Biomedical Science and Engineering</journal-title></journal-title-group><issn pub-type="epub">1937-6871</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/jbise.2012.510071</article-id><article-id pub-id-type="publisher-id">JBiSE-23780</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject></subj-group></article-categories><title-group><article-title>
 
 
  Mixed enzymatic-explant protocol for isolation of mesenchymal stem cells from Wharton’s jelly and encapsulation in 3D culture system
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>aeed</surname><given-names>Azandeh</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mahmoud</surname><given-names>Orazizadeh</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mahmoud</surname><given-names>Hashemitabar</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ali</surname><given-names>Khodadadi</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ali</surname><given-names>Akbar Shayesteh</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Darioush</surname><given-names>Bijan Nejad</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Anneh</surname><given-names>Mohammad Gharravi</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Elham</surname><given-names>Allahbakhshi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Cellular and Molecular Research Center (CMRC), Department of Anatomical science, Faculty of Medicine, Ahvaz Jundishapour University of Medical Sciences (AJUMS), Ahvaz, Iran</addr-line></aff><aff id="aff3"><addr-line>Division of Gastroenterology and Hepatology, Department of Internal Medicine, Imam Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</addr-line></aff><aff id="aff4"><addr-line>School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran</addr-line></aff><aff id="aff2"><addr-line>Cellular and Molecular Research Center (CMRC), Department of Immunology, Ahvaz University of Medical Sciences, Ahvaz, Iran</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>m_orazizadeh@yahoo.com(MO)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>31</day><month>10</month><year>2012</year></pub-date><volume>05</volume><issue>10</issue><fpage>580</fpage><lpage>586</lpage><history><date date-type="received"><day>15</day>	<month>August</month>	<year>2012</year></date><date date-type="rev-recd"><day>15</day>	<month>September</month>	<year>2012</year>	</date><date date-type="accepted"><day>30</day>	<month>September</month>	<year>2012</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  We report combination of explants and enzymatic protocol as mixed enzymatic-explant procedure to faster extraction of MSCs from WJ. Umbilical cords (UC) were collected from Imam Khomini Hospital. For explant outgrowth, 6 - 9 pieces of WJ were transferred onto tissue culture flask and waited for attachment. For mixed enzymatic-explant, 1 cm
  <sup>3</sup> pieces WJ were placed in enzymatic cocktail comprising 4 mg/ml Collagenase Type I and 1 mg/ml Hyaluronidase and 0.1% trypsin-EDTA. Then isolated cells were analyzed for surface cell markers such as CD73, CD31. Isolated 1.0 &#215; 10
  <sup>6</sup> MSCs/ml were encapsulated in alginate hydrogel. Cells with MSCs phenotype were isolated from mixed enzymatic-explant and explant procedures within 24 - 48 hrs and 7 - 10 days, respectively. Both of procedures were shown to form clumps and colonies with dense centers. Phenotypic changes gradually appeared as round cell in UC pieces into homogeneous spindle-shaped and typical fibroblast-like shape cells. By using flow cytometery MSCs showed positive for CD73, and negative for CD31. the morphology of viable MSCs in the beads did not significantly show a different morphology pattern before and after the bead formation process. These findings are indicated that when mixed enzymatic-explant procedure is performed MSCs can be isolated faster and much higher from WJ. These finding is important in comparing with time consuming explants culture for isolation of MSCs.
 
</p></abstract><kwd-group><kwd>Mesenchymal Stem Cells; Isolation; Flow Cytometery; Alginate</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. INTRODUCTION</title><p>Stem cells are precursor cells which have two distinct characteristics: self-renewal and differentiation these unique cells and can be classified according to developmental potential (pluripotential, multipotential, and unipotential cells) and origin (embryonic stem (ES) cells, embryonic germ (EG) cells, embryonal carcinoma (EC) cells, trophoblast stem (TS) cells, and foetal stem cells). They have the potential to develop into many different cell types [<xref ref-type="bibr" rid="scirp.23780-ref1">1</xref>].</p><p>Mesenchymal stem cells (MSCs) are adult stem cells [<xref ref-type="bibr" rid="scirp.23780-ref2">2</xref>] and it is well accepted that umbilical cord a source for mesenchymal cells. Therefore, many studies investigated on isolation and expansion of MSCs from human UC tissue, namely the WJ [<xref ref-type="bibr" rid="scirp.23780-ref3">3</xref>].</p><p>Because UC is a rich source of MSCs, many groups reported isolation of MSCs from different parts of WJ matrix with various derivation protocols. Based on these reports MSCs isolated as a perivascular stem cell from the perivascular regions around the blood vessels [<xref ref-type="bibr" rid="scirp.23780-ref4">4</xref>], as a sub-amnion stem cell from the inner amnion membrane [<xref ref-type="bibr" rid="scirp.23780-ref5">5</xref>], as a human amnion membrane stem cell from the outer amnion membrane [<xref ref-type="bibr" rid="scirp.23780-ref6">6</xref>], as a human umbilical cord matrix stem cell from the intervascular compartment [<xref ref-type="bibr" rid="scirp.23780-ref7">7</xref>] and as a human Wharton’s jelly stem cell; WJSC from the WJ [<xref ref-type="bibr" rid="scirp.23780-ref8">8</xref>].</p><p>Several studies reported 3D culture of MSCs in various scaffold. One of the most frequent biomaterial to fabricate hydrogel scaffold and encapsulation is alginate, which extracted from seaweeds. During cell encapsulation living cells entrapped within hydrogel to provide three dimensional environments [<xref ref-type="bibr" rid="scirp.23780-ref9">9</xref>]. In recent year, studies reported encapsulation of MSCs in scaffolds such as alginate [10,11]. Cell encapsulation have several advantages such as protection cells/tissue fragments from immunological reaction, maintain good viability, the immobilization of cells within microbeads, allows highdensity cell culture and free exchange of nutrients, oxygen, and bioactive products, increase the function of mature cells, but one of major disadvantages of alginate is poor mechanical property.</p><p>Various protocol of MSCs population extraction have been reported from WJ such as explants and enzymatic procedures and results were controversial [12-15]. Therefore, the objective of this study is to introduce isolation of MSCs from WJ suggested new method. We report combination of explants and enzymatic protocol as mixed enzymatic-explant to faster extraction MSCs from Wharton’s jelly. We compared the morphological changes of isolated MSCs in two different 2D and 3D culture in alginate scaffold.</p></sec><sec id="s2"><title>2. MATERIAL AND METHODS</title><sec id="s2_1"><title>2.1. Materials</title><p>Phosphate-buffered saline (PBS), fetal bovine serum (FBS), Dulbecco’s Modified Eagle Medium (DMEM), antibiotic (penicillin–streptomycin), alginate and trypsin, HEPES, L-glutamine, Collagenase Type I, Hyaluronidase, trypsin-EDTA, NaCl and CaCl<sub>2</sub> were purchased from Sigma-Aldrich (MO, USA). All chemicals were used directly without further purification. All chemicals were purchased from Sigma (St. Louis, MO) unless otherwise noted.</p></sec><sec id="s2_2"><title>2.2. Ethic Approval</title><p>The study protocol was approved by the Ethics Committee of Ahvaz Jundishapour University of Medical Sciences (AJUMS) and all procedures were performed according to ethical committee approval. UC cells were harvested from the umbilical cords of healthy full-term infants born by cesarean section (C/S). Before collection of UC informed consent received from the mothers.</p></sec><sec id="s2_3"><title>2.3. Collection and Transport of UCs from Hospital to Laboratory</title><p>Protocol design for this study is presented in <xref ref-type="fig" rid="fig1">Figure 1</xref>. According to this protocol, the work was divided into five steps; isolation phases (by explant or mixed enzymatic-explant procedures), proliferation of MSCs, flowcytometry with negative and positive surface markers, two dimensional and three dimensional cultures and evaluation of MSCs (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><p>All of UC were collected from Obstetrics Department of Ahvaz Jundishapour University of Medical Sciences (AJUMS) and approximately, 20 cm length pieces cut from each UC. Immediately after C/S, the cords were transferred to sterile containers containing sterile transport medium (DMEM (low glucose) containing 100 U/mL penicillin, 100 mg/mL streptomycin, and 0.25 mg/mL amphotericin B. and stored at 4˚C for 2 - 6 hrs before tissue processing. Collected UC were transported to laboratory of Cellular and Molecular Research Center (CMRC), Department of Anatomical Sciences, Faculty of Medicine, Ahvaz Jundishapour University of Medical Sciences (AJUMS).All the procedure of collection and transport of C/S were performed under sterile conditions.</p></sec><sec id="s2_4"><title>2.4. Extraction of WJ</title><p>Isolation and propagation of MSCs from above small pieces from WJ were carried out according to the protocol is found elsewhere. At least two investigators cooperated in tissue processing and Wharton’s jelly dissection. MSCs isolation were performed in cold, sterile dissection solution consisting of 1% antibiotic solution in PBS to give 100 U/mL penicillin, 100 mg/mL streptomycin, and 0.25 mg/mL amphotericin B. Briefly, in laminar hood and under sterile conditions, each piece of umbilical cord was cut into smaller 2 - 4-cm length pieces. The cord was washed gently with carrying solution three times and squeezed with curved forceps to remove trapped blood within the umbilical blood vessels. The washing was repeated until remove any blood or blood clots. At the external surface of each piece, horizontal sections are engraved with a sterile scalpel then cut open lengthwise</p><p>with sterile scissors and forceps and cut the outer sheath of UC sections to extract its inner surface containing the WJ. Then, the exposed vein and arteries were removed by pulling with forceps and peeled away from the WJ. Extracted WJ was cut into 3 - 5-mm pieces with a scalpel and washed again with sterile dissection solution [12-15] (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p><sec id="s2_4_1"><title>2.4.1. Isolation of MSCs with Explants Procedure</title><p>For explant outgrowth, 6 - 9 pieces were transferred onto tissue culture 25-cm<sup>2</sup> T-flasks and were left undisturbed for 3 - 5 minutes until attachment onto flask. Then, complete culture medium (CCM) composed of DMEM (low glucose) with 2 mM L-glutamine, supplemented with 20% fetal bovine serum, 100 U penicillin/streptomycin was added. The culture flask was left undisturbed for 3 - 4 days and maintained at 37˚C in a humidified atmosphere containing 5% CO<sub>2</sub>. The medium changed every 2 - 3 days thereafter [12-15] (Figures 2 and 3).</p></sec><sec id="s2_4_2"><title>2.4.2. Isolation of MSCs with Mixed Enzymatic-Explant Digestion</title><p>After removing blood vessels and outer sheath of UC to</p><p>allow only the WJ to come into direct contact with the enzymatic solution, extracted WJ cut into approximately 1 cm<sup>3</sup> pieces and washed with PBS. WJ, were then placed in 50 ml falcon tube containing LG-DMEM medium with enzymatic cocktail comprising 4 mg/ml Collagenase Type I and 1 mg/ml Hyaluronidase and incubated for 1hr. followed by 0.1% trypsin-EDTA for 30 minutes at 37˚C in a humidified atmosphere containing 5% CO<sub>2</sub> to loosening up of the WJ without complete digestion (<xref ref-type="fig" rid="fig4">Figure 4</xref>). After the incubation period, the WJ pieces were washed with PBS solution and transferred to a new 50 ml falcon tube and procedure of explant outgrowth was repeated (<xref ref-type="fig" rid="fig4">Figure 4</xref>). The digested suspendsion was diluted 1:2 with PBS solution and passed through a 70 μm nylon filter (Falcon, BD, Oxford, UK), diluted with LG-DMEM, and centrifuged at 300 g for 10 min. Supernatant discarded and cell pellets resuspended in culture medium (CCM) composed of DMEM (low glucose) with 2 mM L-glutamine, supplemented with 20% fetal bovine serum, 100 U penicillin/streptomycin.</p><p>The entire tissue flask containing the WJ pieces in either above mentioned procedure was left undisturbed at 37˚C in a humidified atmosphere containing 5% CO<sub>2</sub> until migration of MSCs from WJ [12-15].</p></sec></sec><sec id="s2_5"><title>2.5. Cell Expansion</title><p>Cells were allowed to adhere to culture flask and nonadherent cells were removed by changing the medium. When the adherent cells reached confluence, covering 70% - 80% of culture flask, the cells were washed once with PBS and trypsinized with 0.25% trypsin-EDTA. After detachment of the adherent cells, suspension centrifuged at 200 - 300 g for 10 min, supernatant discarded, cell pellets washed in medium. Then were resuspended</p><p>in medium and transferred to new culture flask at a density 250 &#215; 10<sup>3</sup> cells/cm<sup>2</sup>. During subculture, they were passaged every 5 days; medium was replaced every 3 days. Expansion medium consisted of DMEM (low glucose) with 2 mM L-glutamine, supplemented with 20% fetal bovine serum, 100 U penicillin/streptomycin. Adherent cells were cultured until they reached 80% - 90% confluence [12-15]. For further passaging above procedures were conducted again.</p></sec><sec id="s2_6"><title>2.6. MSCs Morphology Analysis</title><p>The MSCs cultures were routinely visualized using an inverted research microscope IX50 (Olympus, Japan) and the phenotype and growth of primary and passaged cells were monitored Photomicrographs were taken with a digital camera model of Cyber-shot DSC-HX9V (Sony, Japan) under inverted phase-contrast optics.</p></sec><sec id="s2_7"><title>2.7. Biomarkers Detection of MSCs by Using Flow Cytometry</title><p>MSCs were analyzed for surface cell markers by Flow cytometry as described in the Supplemental Data. Cells were trypsinized. And total of 5 &#215; 10<sup>5</sup> cells were resuspended in PBS and 5% FBS incubated with phycoerythrin (PE)- or fluorescein isothiocyanate (FITC)-conjugated antibodies against CD73, CD31 and IgG (ebioscince, USA) for 30 min at dark room at 4˚C. Excess antibody was removed by washing and detection of PE and FITC labeling was accomplished on a Dako Glaxy flocytometer. Mouse isotype-matched Antibody (Ab) were used as controls (ebioscince, USA) [12-15].</p></sec><sec id="s2_8"><title>2.8. Cell Encapsulation of MSCs in Hydrogel Scaffold</title><p>For alginate hydrogel scaffolding, alginate of 2.0% w/v were prepared as previously described by adding alginic acid sodium salt from brown algae, into 0.15 M NaCl, and 0.025 M HEPES in deionized water by stirring. The solution was then sterilized via 0.45-nm filter [<xref ref-type="bibr" rid="scirp.23780-ref14">14</xref>].</p><p>Isolated MSCs (1&#215; 10<sup>6</sup> cells/ml) were resuspended in 2 - 5 ml prepared hydrogel and then slowly expressed through a 22 gauge needle into a 102 mM CaCl<sub>2</sub> solution. The hydrogels containing encapsulated hMSC were allowed to polymerize for a period of 10 minutes in the CaCl<sub>2</sub> solution. Next, microcapsules were washed 2 - 3 times 10 volumes of 0.15 M NaCl. The alginate/MSCs constructs were finally placed in culture flask with complete culture medium composed of DMEM (low glucose) with 2 mM L-glutamine, supplemented with 20% fetal bovine serum, 100 U penicillin/streptomycin and with controlled environmental conditions (37˚C, 5% CO<sub>2</sub>, 95% O<sub>2</sub> and 95% humidity) [10,11].</p></sec><sec id="s2_9"><title>2.9. Histological Evaluation</title><p>In the end of MSCs 3D culture in hydrogel scaffold, the constructs were fixed in Bouin’s fixative solution, dehydrated through a series of graded alcohols, cleared with xylene, and embedded in paraffin wax. Five to sevenmicrometer sections were cut, and then stained with hematoxylin &amp; eosin.</p></sec><sec id="s2_10"><title>2.10. Statistical Analysis</title><p>Data were given as mean &#177; standard deviation and were statistically analyzed. The difference between the mean was considered significant when p &lt; 0.05.</p></sec></sec><sec id="s3"><title>3. RESULTS</title><sec id="s3_1"><title>3.1. Isolation of MSCs with Explant and Mixed Enzymatic-Explant</title><p>Cells with a MSCs phenotype were isolated from mixed enzymatic-explant within 24 - 48 h of collection, while in explant procedure through 7 - 10 days after collection, MSCs phenotype cells were isolated. Therefore, when compared isolation of MSC from explant culture was much slower to the enzymatic-explant cultures (2 &#177; 8.7 days compared to 15 &#177; 9.9 days, respectively) which led to confluence was reached much slower compared to the same enzymatic cultures. Although cell growth increased with time in enzymatic-explant culture, the increases were not as high as for with explants culture. Also enzymatic cultures produced MSCs at high efficiency (Figures 3 and 4).</p></sec><sec id="s3_2"><title>3.2. Cell Expansion</title><p>There was no difference between explant and a mixed enzymatic-explant culture in proliferation after initial cell isolation either 24 - 48 hrs. In enzymatic-explant culture or 7 - 10 days in explant culture. Both of procedures were shown to form clumps and colonies with dense centers. These colonized populations were observed at the early stages of culture. Cells were cultured and maintained until passage 7 - 8 (Figures 3 and 4).</p></sec><sec id="s3_3"><title>3.3. MSCs Morphology Analysis</title><p>Phenotypic changes gradually appeared as round cell in UC pieces into homogeneous spindle-shape and typical fibroblast-like shape cells which continued to proliferate. When these spindle-shaped cells appeared in culture, colonies formed thereafter. Although hMSC maintained their characteristics such as the fibroblastic morphology over the passages, primary and first-passage cultures displayed an epithelioid or short fibroblastic-like phenoltype but in further passages, cell transformed into long spindle-shaped fibroblast-like cells (<xref ref-type="fig" rid="fig5">Figure 5</xref>).</p></sec><sec id="s3_4"><title>3.4. Immunophenotypic Characterization of MSCs</title><p>The immunophenotype of the WJSC was similar in both enzymztic and explant and cultured stem cells were positive for general mesenchymal markers such, CD73, but negative against hematopoietic markers, CD31 (<xref ref-type="fig" rid="fig1">Figure 1</xref>) although there were differences in growth rates. Therefore these data suggested that the UC derived cell is one of the MSCs populations similar to those from bone marrow or adipose tissue (<xref ref-type="fig" rid="fig6">Figure 6</xref>).</p></sec><sec id="s3_5"><title>3.5. 3D Culture</title><p>Homogenous alginate beads successfully produced. Morphology of viable MSCs in the beads did not significantly revealed a different morphology pattern before and after the bead formation process. They had round shaped similar to round shape of stem cells in UC.</p><p>After 7 - 10 days of culture, the microscopic pictures suggested formation of three-dimensional cell aggregates</p><p>as mounds, and the mounds in 3D were larger in size and greater in numbers compared with 2D (Figures 5 and 7).</p></sec><sec id="s3_6"><title>3.6. Histological Evaluation</title><p>Typical histological appearance of sections revealed evidence of round cells with clear cytoplasm and nucleus which aggregated in some part of scaffold.</p></sec></sec><sec id="s4"><title>4. DISCUSSION</title><p>In present study, we examined isolation of MSCs from umbilical cord with different protocols: explants and mixed enzymatic-explant procedure. Results indicated that numbers of adherent MSCs in mixed explants-enzymatic protocol were much higher and faster that explants procedure.</p><p>In present study we used 4 mg/ml Collagenase Type I and 1 mg/ml Hyaluronidase and incubated for 1 hr. followed by 0.1% trypsin-EDTA for 30 minutes.</p><p>In literature different protocols have been reported to isolation of MSCs from UC with different findings. Investigators examined different dose and time: 2.7 mg/mL collagenase type I, 0.7 mg/mL hyaluronidase 2.5% trypsin, 3 h in PBS [<xref ref-type="bibr" rid="scirp.23780-ref15">15</xref>], 0.075% collagenase type II for 30 min, 0.125% trypsin for 30 min [<xref ref-type="bibr" rid="scirp.23780-ref16">16</xref>], collagenase type B (1 μg/mL) in DMEM-Ham’s F12 (1:1), 10% FBS for 4 h [<xref ref-type="bibr" rid="scirp.23780-ref17">17</xref>], collagenase, hyaluronidase, trypsin, 45 - 60 min [<xref ref-type="bibr" rid="scirp.23780-ref7">7</xref>], collagenase 1 mg/mL (PBS) for 18 - 24 h [<xref ref-type="bibr" rid="scirp.23780-ref4">4</xref>], enzyme cocktail: 4 mg/mL BSA, 4 mg/mL collagenase, 1 mg/mL hyaluronidase, 0.1 mg/mL trypsin inhibitor and 200 mg/mL DNAse II [<xref ref-type="bibr" rid="scirp.23780-ref18">18</xref>], collagenase for 18 h, washed, 2.5% trypsin for 30 min with agitation.</p><p>In our study, isolated MSCs expressed strength mesenchymal markers such as CD73, while there negative against hematopoietic markers, CD31. Therefore these data suggested that the UC derived cell is one of the MSCs populations similar to those from bone marrow or adipose tissue. Our finding is consistent with other studies [19-21].</p><p>When MSCs migrated from WJ into culture flask, they</p><p>have round shape cell morphology and changed morphological into spindle-shaped and fibroblast like cells. These features were observed by several studies, and they found morphology of MSCs similar to our findings [15,16,22].</p><p>In present study, encapsulated MSCs in alginate hydrogel had round shaped similar to round shape of stem cells in UC. Our finding is consistent study of Penolazzi et al. 2010 that “The microencapsulation procedure did not alter the morphology and viability of the encapsulated MSCs” [<xref ref-type="bibr" rid="scirp.23780-ref10">10</xref>].</p></sec><sec id="s5"><title>5. CONCLUSION</title><p>These finding indicated that when mixed enzymaticexplant procedure is performed MSCs can be isolated faster and much higher from Wharton’s jelly. These findings are important in comparing with time and consuming explants culture which for isolation of MSCs.</p></sec><sec id="s6"><title>6. ACKNOLEDGEMENTS</title><p>This work is a part of Ph.D thesis of Saeed Azandeh. This work was funded by the Cellular and Molecular Research Center (CMRC), Research deputy of Ahvaz Jundishapour University of Medical Sciences. We thank Mrs. Fereshteh Negad Dehbashi.</p></sec><sec id="s7"><title>REFERENCES</title></sec><sec id="s8"><title>ABBREVIATIONS</title></sec><sec id="s9"><title>NOTES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.23780-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Watt, F.M., and B.L.M. Hogan. (2000) Out of Eden: Stem cells and their niches. Science, 287:1427-143... DOI: 10.1126/science.287.5457.1427</mixed-citation></ref><ref id="scirp.23780-ref2"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname> 
Zhang</surname><given-names> X.Y.</given-names></name>,<name name-style="western"><surname> J.S. Li</surname><given-names> J. Nie</given-names></name>,<name name-style="western"><surname> K. Jiang</surname><given-names> Z.K. Zhen</given-names></name>,<name name-style="western"><surname> J.J. Wang</surname><given-names> and L. Shen. </given-names></name>,<etal>et al</etal>. (<year>2010</year>)<article-title>Differentiation Character of Adult Mesenchymal Stem Cells and Transfection of MSCs with Lentiviral Vectors</article-title><source> J Huazhong U Sci-Med</source><volume> 30</volume>,<fpage> 687</fpage>-<lpage>693 DOI: 10</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.23780-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple"> 
Troyer, D.L., and M.L. Weiss. (2008) Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells, 26, 591-599. DOI:10.1634/stemcells.2007-0439</mixed-citation></ref><ref id="scirp.23780-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple"> 
Sarugaser, R., D. Lickorish, D. Baksh, M.M. Hosseini, and J.E. Davies. (2005) Human umbilical cord perivascular (HUCPV) cells: A source of mesenchymal progenitors. Stem Cells, 23, 220-229. DOI:10.1634/stemcells.2004-0166</mixed-citation></ref><ref id="scirp.23780-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple"> 
Ruetze, M., S. Gallinat, I.J. Lim, E. Chow, T.T. Phan, F. Staeb, H. Wenck, W. Deppert, and A. Knott. (2008) Common features of umbilical cord epithelial cells and epidermal keratinocytes. J Dermatol Sci, 50, 227-231. DOI:10.1016/j.jdermsci.2007.12.006</mixed-citation></ref><ref id="scirp.23780-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple"> 
Ilancheran, S., A. Michalska, G. Peh, E.M. Wallace, M. Pera, and U. Manuelpillai. (2007) Stem cells derived from human fetal membranes display multilineage differentiation potential. Biol Reprod, 77, 577-588. DOI: 10.1095/biolreprod.106.055244</mixed-citation></ref><ref id="scirp.23780-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple"> 
Weiss, M.L., S. Medicetty, A.R. Bledsoe, R.S. Rachakatla, M. Choi, S. Merchav, Y.Q. Luo, M.S. Rao, G. Velagaleti, and D. Troyer. (2006) Human umbilical cord matrix stem cells: Preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells, 24, 781-792 DOI:10.1634/stemcells.2005-0330</mixed-citation></ref><ref id="scirp.23780-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple"> 
Fong, C.Y., M. Richards, N. Manasi, A. Biswas, and A. Bongso. (2007) Comparative growth behaviour and characterization of stem cells from human Wharton's jelly. Reprod Biomed Online, 15, 708-718. DOI: 10.1016/S1472-6483(10)60539-1</mixed-citation></ref><ref id="scirp.23780-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple"> 
Chang, P.L. (1999) Encapsulation for somatic gene therapy. Ann Ny Acad Sci, 875, 146-158. DOI:10.1111/j.1749-6632.1999.tb08500.x</mixed-citation></ref><ref id="scirp.23780-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple"> 
Penolazzi, L., E. Tavanti, R. Vecchiatini, E. Lambertini, F. Vesce, R .Gambari, S. Mazzitelli, F. Mancuso, G. Luca, C. Nastruzzi, and R. Piva. (2010) Encapsulation of mesenchymal stem cells from Wharton’s jelly in alginate microbeads. Tissue Eng Part C-Me, 16, 141-155. DOI:10.1089/ten.tec.2008.0582.</mixed-citation></ref><ref id="scirp.23780-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple"> 
Park, J.S., D.G. Woo, H.N. Yang, H.J. Lim, K.M. Park, K. Na, and K.H. Park. (2010) Chondrogenesis of human mesenchymal stem cells encapsulated in a hydrogel construct: Neocartilage formation in animal models as both mice and rabbits. J Biomed Mater Res A, 92, 988- 996. DOI: 10.1002/jbm.a.32341</mixed-citation></ref><ref id="scirp.23780-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple"> 
Fong, C.Y., A. Subramanian, A. Biswas, K. Gauthaman, P. Srikanth, M.P. Hande, and A. Bongso. (2010) Derivation efficiency, cell proliferation, freeze-thaw survival, stem-cell properties and differentiation of human Wharton's jelly stem cells. Reprod Biomed Online 21, 391-401. DOI:10.1016/j.rbmo.2010.04.010</mixed-citation></ref><ref id="scirp.23780-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple"> 
Salehinejad, P., N.B. Alitheen, A.M. Ali, A.R. Omar, M. Mohit, E. Janzamin, F.S. Samani, Z. Torshizi ,and S.N. Nematollahi-Mahani. (2012) Comparison of different methods for the isolation of mesenchymal stem cells from human umbilical cord Wharton's jelly. In Vitro Cell Dev-An 48, 75-83. DOI: 10.1007/s11626-011-9480-x</mixed-citation></ref><ref id="scirp.23780-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple"> 
Montanucci, P., G. Basta, T. Pescara, I. Pennoni, F. Di Giovanni ,and R. Calafiore. (2011) New simple and rapid method for purification of mesenchymal stem cells from the human umbilical cord Wharton jelly. Tissue Eng Part A 17, 2651-2661. DOI:10.1089/ten.tea.2010.0587</mixed-citation></ref><ref id="scirp.23780-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple"> 
Tsagias ,N., I. Koliakos, V. Karagiannis, M. Eleftheriadou, and G.G. Koliakos. (2011) Isolation of mesenchymal stem cells using the total length of umbilical cord for transplantation purposes. Transfusion Med 21, 253-261. DOI: 10.1111/j.1365-3148.2011.01076.x</mixed-citation></ref><ref id="scirp.23780-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple"> 
Lu, L.L., Y.J. Liu, S.G. Yang, Q.J. Zhao, X. Wang ,W. Gong, Z.B. Han, Z.S. Xu, Y.X. Lu, D. Liu, Z.Z. Chen, and Z.C. Han. (2006) Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 91, 1017-1026.</mixed-citation></ref><ref id="scirp.23780-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple"> 
Karahuseyinoglu ,S., O. Cinar, E. Kilic, F. Kara, G.G. Akay, D.O. Demiralp, A. Tukun, D. Uckan, and A. Can. (2007) Biology of stem cells in human umbilical cord stroma: In situ and in vitro surveys. Stem Cells 25, 319-331. DOI: 10.1634/stemcells.2006-0286</mixed-citation></ref><ref id="scirp.23780-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple"> 
Meyer, T., V. Lechner, K. Ulrichs, J. Dietl, B. Hocht, and A. Thiede. (2006) Isolation and characterization of umbilical cord mesenchymal stem cells: Potent cells for cell-based therapies in pediatric surgery? Cytotherapy 8, 39-39. DOI: 10.1007/s10353-008-0417-x</mixed-citation></ref><ref id="scirp.23780-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple"> 
Manca, M.F. ,I. Zwart, J. Beo, R. Palasingham, L.S. Jen, R. Navarrete, J. Girdlestone, and C.V. Navarrete. (2008) Characterization of mesenchymal stromal cells derived from full-term umbilical cord blood. Cytotherapy 10, 54-68 DOI:10.1080/14653240701732763</mixed-citation></ref><ref id="scirp.23780-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple"> 
Han, Y.F., J.K. Chai, T.J. Sun, D.J. Li, and R. Tao. (2011) Differentiation of human umbilical cord mesenchymal stem cells into dermal fibroblasts in vitro. Biochem Bioph Res Co 413, 561-565. DOI: org/10.1016/j.bbrc.2011.09.001</mixed-citation></ref><ref id="scirp.23780-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple"> 
Dominici, M., K. Le Blanc, I. Mueller, I. Slaper-Cortenbach, F.C. Marini, D.S. Krause, R.J. Deans, A. Keating, D.J. Prockop, and E.M. Horwitz. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315-317. DOI:10.1080/14653240600855905</mixed-citation></ref><ref id="scirp.23780-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple"> 
Wang, H.S., S.C. Hung, S.T. Peng, C.C. Huang, H.M. Wei, Y.J. Guo, Y.S. Fu, M.C. Lai, and C.C. Chen. (2004) Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 22, 1330-1337. DOI:10.1634/stemcells.2004-0013.</mixed-citation></ref></ref-list></back></article>